Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Innovation at RUSH
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Management of children with multiple sclerosis.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Epidural blood patch in a patient with multiple sclerosis: is it safe?
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
mfERG_LAB: Software for processing multifocal electroretinography signals.
Review of MR elastography applications and recent developments.
MiR-126: a novel route for natalizumab action?
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
The initiation and prevention of multiple sclerosis.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Biochemical Markers of Autoimmune Diseases of the Nervous System.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
Multiple sclerosis: Does aggressive MS warrant aggressive treatment?
Is it time for a new global classification of multiple sclerosis?
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Pages
« first
‹ previous
…
165
166
167
168
169
170
171
172
173
…
next ›
last »